| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer
|
Yamada, Kazuhiko
|
|
2016
|
78 |
3 |
p. 501-507
|
artikel
|
| 2 |
A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer
|
Beg, Muhammad S.
|
|
2016
|
78 |
3 |
p. 577-584
|
artikel
|
| 3 |
A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer
|
Renouf, D. J.
|
|
2016
|
78 |
3 |
p. 541-545
|
artikel
|
| 4 |
A phase I study of the combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, irinotecan and bevacizumab
|
Takahashi, Naoki
|
|
2016
|
78 |
3 |
p. 567-575
|
artikel
|
| 5 |
BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing regimen
|
Chae, Jung-woo
|
|
2016
|
78 |
3 |
p. 623-632
|
artikel
|
| 6 |
Editorial
|
|
|
2016
|
78 |
3 |
p. 445
|
artikel
|
| 7 |
Editorial
|
|
|
2016
|
78 |
3 |
p. 443-444
|
artikel
|
| 8 |
Effects of a bolus injection of 5-fluorouracil on dihydropyrimidine dehydrogenase activity in rats receiving continuous infusion of 5-fluorouracil
|
Kobuchi, Shinji
|
|
2016
|
78 |
3 |
p. 517-523
|
artikel
|
| 9 |
Ethnic sensitivity assessment of the antibody–drug conjugate trastuzumab emtansine (T-DM1) in patients with HER2-positive locally advanced or metastatic breast cancer
|
Li, Chunze
|
|
2016
|
78 |
3 |
p. 547-558
|
artikel
|
| 10 |
Model-based prediction of progression-free survival in patients with first-line renal cell carcinoma using week 8 tumor size change from baseline
|
Claret, Laurent
|
|
2016
|
78 |
3 |
p. 605-610
|
artikel
|
| 11 |
Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study)
|
Takahashi, Takao
|
|
2016
|
78 |
3 |
p. 585-593
|
artikel
|
| 12 |
Myelosuppression by chemotherapy in obese patients with gynecological cancers
|
Kamimura, Kensuke
|
|
2016
|
78 |
3 |
p. 633-641
|
artikel
|
| 13 |
Occurrence of hepatotoxicity with pazopanib and other anti-VEGF treatments for renal cell carcinoma: an observational study utilizing a distributed database network
|
Shantakumar, Sumitra
|
|
2016
|
78 |
3 |
p. 559-566
|
artikel
|
| 14 |
Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics
|
Aboel Dahab, Ali
|
|
2016
|
78 |
3 |
p. 465-489
|
artikel
|
| 15 |
Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients
|
Madan, Ankit
|
|
2016
|
78 |
3 |
p. 509-515
|
artikel
|
| 16 |
Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours
|
Patnaik, Amita
|
|
2016
|
78 |
3 |
p. 491-500
|
artikel
|
| 17 |
Protein expression of ATP-binding cassette transporters ABCC10 and ABCC11 associates with survival of colorectal cancer patients
|
Krizkova, V.
|
|
2016
|
78 |
3 |
p. 595-603
|
artikel
|
| 18 |
Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin
|
Zhang, Xia
|
|
2016
|
78 |
3 |
p. 655-659
|
artikel
|
| 19 |
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours
|
Yonemori, Kan
|
|
2016
|
78 |
3 |
p. 525-531
|
artikel
|
| 20 |
SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia
|
Kim, Jeong-Hyun
|
|
2016
|
78 |
3 |
p. 533-540
|
artikel
|
| 21 |
SM-1, a novel PAC-1 derivative, activates procaspase-3 and causes cancer cell apoptosis
|
Chen, Yanfen
|
|
2016
|
78 |
3 |
p. 643-654
|
artikel
|
| 22 |
The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines
|
Fiedor, Elżbieta
|
|
2016
|
78 |
3 |
p. 611-622
|
artikel
|
| 23 |
Therapeutic drug monitoring of 5-fluorouracil
|
Lee, James J.
|
|
2016
|
78 |
3 |
p. 447-464
|
artikel
|
Tijdschrift beschrijving